Literature DB >> 21787887

High altitude simulation, substance P and airway rapidly adapting receptor activity in rabbits.

R Bhagat1, A Yasir, A Vashisht, R Kulshreshtha, S B Singh, K Ravi.   

Abstract

To investigate whether there is a change in airway rapidly adapting receptor (RAR) activity during high altitude exposure, rabbits were placed in a high altitude simulation chamber (barometric pressure, 429 mm Hg). With 12 h exposure, when there was pulmonary congestion, an increase in basal RAR activity was observed. With 36 h exposure, when there was alveolar edema, there was a further increase in basal RAR activity. In these backgrounds, there was an increase in the sensitivity of the RARs to substance P (SP). To assess whether there was an increase in lung SP level, neutral endopeptidase activity was determined which showed a decrease in low barometric pressure exposed groups. It is concluded that along with the SP released, pulmonary congestion and edema produced, respectively by different durations of low barometric pressure exposure cause a progressive increase in RAR activity which may account for the respiratory symptoms reported in climbers who are unacclimatized.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787887     DOI: 10.1016/j.resp.2011.07.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

1.  Systemic Blood Predictors of Elevated Pulmonary Artery Pressure Assessed by Non-invasive Echocardiography After Acute Exposure to High Altitude: A Prospective Cohort Study.

Authors:  Shi-Zhu Bian; Chen Zhang; Rong-Sheng Rao; Xiao-Han Ding; Lan Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-10

2.  Prophylactic efficacy of Quercetin in ameliorating the hypoxia induced vascular leakage in lungs of rats.

Authors:  Ankit Tripathi; Bhuvnesh Kumar; Sarada S K Sagi
Journal:  PLoS One       Date:  2019-06-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.